Filters
Custom request?
Type
Production region
Qualifications
Country of origin
Myo-Inositol API Manufacturers & Suppliers
2 verified results
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Commercial-scale Suppliers
All certificates
All certificates
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
scyllo-inositol | CAS No: 488-59-5 | GMP-certified suppliers
A medication that is under investigation for potential use in neurodegenerative conditions such as Alzheimer disease, supporting research-focused development needs for specialized API sourcing.
Therapeutic categories
Product Snapshot
- Scyllo-inositol is an oral small-molecule API
- Its primary development focus is neurodegenerative and cognitive-disorder indications
- It is an investigational compound with no FDA or EMA approvals to date
Clinical Overview
The principal clinical context explored to date is Alzheimer disease, where scyllo-inositol has been evaluated for potential modulation of amyloid-related pathophysiology. No formal, approved therapeutic indication has been established. Clinical data remain limited, and its development status varies across regions.
A defined pharmacodynamic profile has not been fully characterized in humans. Experimental data suggest that stereospecific interactions with amyloid assemblies may influence aggregation behavior, but these findings have not been translated into validated clinical mechanisms. Overall pharmacological actions therefore remain subject to ongoing investigation.
Specific mechanistic pathways in humans have not been confirmed. Inositol stereoisomers can participate in signaling networks, but scyllo-inositol’s direct molecular targets, downstream pathways, and therapeutic relevance have not been conclusively determined.
Comprehensive ADME data are limited. Available early-phase studies indicate oral administration has measurable systemic exposure, yet absorption characteristics, distribution patterns including central nervous system penetration, metabolic pathways, and elimination kinetics require further clarification. No well-defined drug interaction parameters are available.
Safety information is derived mainly from small investigational studies. Reported tolerability has varied, and dose-dependent gastrointestinal and metabolic findings have been described, though consistent toxicity profiles have not been established. Long-term safety, especially in older adults or those with comorbidities, remains insufficiently characterized.
For API sourcing, suppliers should provide robust identity confirmation, control of stereoisomeric purity, and compliance with applicable investigational-use quality standards. Analytical verification of impurity profiles and stability characteristics is essential for research or developmental use.
Identification & chemistry
| Generic name | scyllo-inositol |
|---|---|
| Molecule type | Small molecule |
| CAS | 488-59-5 |
| UNII | 1VS4X81277 |
| DrugBank ID | DB03106 |
Pharmacology
Targets
| Target | Organism | Actions |
|---|---|---|
| Glucosylceramidase | Humans | |
| 1-phosphatidylinositol phosphodiesterase | Bacillus cereus | |
| CDP-diacylglycerol--inositol 3-phosphatidyltransferase | Humans | inhibitor |
Formulation & handling
- Highly water‑soluble small molecule suitable for aqueous oral or parenteral formulations with minimal need for solubilizers.
- Very low LogP and polar character may require permeability‑enhancing strategies for oral delivery.
- Solid, chemically simple cyclohexanol derivative with good aqueous stability, enabling straightforward handling and solution preparation.
Regulatory status
Myo-Inositol is a type of Vitamins
Vitamins are an essential subcategory of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a crucial role in maintaining optimal health and well-being. These organic compounds are required in small quantities by the human body to support various metabolic processes and ensure proper functioning of bodily systems. Vitamins can be broadly classified into two groups: fat-soluble vitamins (such as vitamins A, D, E, and K) and water-soluble vitamins (including vitamin C and B-complex vitamins). Each vitamin has a specific role and function within the body.
Pharmaceutical APIs in the vitamin subcategory are carefully synthesized or extracted to meet stringent quality standards and ensure purity, efficacy, and safety. They are used as active ingredients in the formulation of various pharmaceutical products, including dietary supplements, fortified foods, and pharmaceutical formulations.
Vitamin APIs are commonly utilized in the pharmaceutical industry for their therapeutic benefits. For instance, vitamin D API is widely prescribed to treat deficiencies and maintain optimal bone health, while vitamin C API is utilized for its antioxidant properties and immune-boosting effects. B-complex vitamins, such as vitamin B12 API, are essential for energy production and nerve function.
Overall, vitamins are integral to maintaining good health, and pharmaceutical APIs in this subcategory play a vital role in providing these essential nutrients to individuals through various pharmaceutical and dietary applications.
Myo-Inositol (Vitamins), classified under Therapeutic Nutrients/Minerals/Electrolyte
Therapeutic Nutrients/Minerals/Electrolytes: A Comprehensive Technical DescriptionTherapeutic nutrients, minerals, and electrolytes are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to support and enhance overall health and well-being. These compounds play a crucial role in maintaining the body's physiological balance, aiding in various metabolic processes, and addressing specific deficiencies.
Therapeutic nutrients encompass a broad range of substances, including vitamins, minerals, and electrolytes. Vitamins are organic compounds required in small quantities for proper bodily functions and are essential for growth, development, and disease prevention. Minerals, on the other hand, are inorganic substances that support numerous physiological processes, such as bone formation, nerve function, and energy production.
Electrolytes are minerals that carry an electric charge when dissolved in bodily fluids, including sodium, potassium, calcium, magnesium, and chloride. They play a crucial role in maintaining proper hydration, nerve impulses, muscle contractions, and pH balance.
Pharmaceutical APIs in the Therapeutic Nutrients/Minerals/Electrolyte category are designed to address specific deficiencies or imbalances in the body. These APIs are often used in the formulation of dietary supplements, nutritional products, and therapeutic treatments. They are manufactured under stringent quality control guidelines to ensure purity, potency, and bioavailability.
Therapeutic nutrients/minerals/electrolytes APIs are available in various forms, including tablets, capsules, powders, and liquid formulations. They are formulated to meet specific dosage requirements and can be combined with other ingredients for targeted health benefits.
Overall, therapeutic nutrients, minerals, and electrolytes APIs are essential components in maintaining optimal health. Their use helps address deficiencies, support bodily functions, and promote overall well-being. Pharmaceutical companies and healthcare professionals rely on these high-quality APIs to develop effective and safe products that contribute to a healthier population.
Myo-Inositol API manufacturers & distributors
Compare qualified Myo-Inositol API suppliers worldwide. We currently have 2 companies offering Myo-Inositol API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.
| Supplier | Type | Country | Product origin | Certifications | Portfolio |
|---|---|---|---|---|---|
| Qinyang Pharmaceutical Fa... | Producer | China | China | CoA, GMP, Other, MSDS | 1 products |
| Zhucheng Haotian Pharm | Producer | China | China | CoA, WC | 1 products |
When sending a request, specify which Myo-Inositol API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).
Use the list above to find high-quality Myo-Inositol API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.
Frequently asked questions about Myo-Inositol API
Sourcing
Which documents are typically required when sourcing Myo-Inositol API?
Which manufacturers are known to produce Myo-Inositol API?
How can I request quotes for Myo-Inositol API from GMP suppliers?
Is a GMP audit report available for Myo-Inositol manufacturers?
How many suppliers offer Myo-Inositol API on Pharmaoffer?
Which countries are known to manufacture Myo-Inositol API?
Which certifications do suppliers of Myo-Inositol usually hold?
Technical
What is Myo-Inositol (CAS 488-59-5) used for?
Which therapeutic class does Myo-Inositol fall into?
What should someone know about the safety or toxicity profile of Myo-Inositol?
What are important formulation and handling considerations for Myo-Inositol as an API?
Is Myo-Inositol a small molecule?
Are there special stability concerns for oral Myo-Inositol?
Pharmaoffer
How does Pharmaoffer’s Smart Sourcing Service help with Myo-Inositol procurement?
Is Myo-Inositol included in the PRO Data Insights coverage?
Where can I access the API market report for Myo-Inositol?
